Literature DB >> 24078452

The VDR gene FokI polymorphism and ovarian cancer risk.

Hui Xu, Su Li, Jian-Qing Qiu, Xiao-Lin Gao, Ping Zhang, Yong-Xia Yang.   

Abstract

The polymorphism of vitamin D receptor (VDR) gene is demonstrated to affect the activity of its encoding protein and the subsequent downstream effects mediated by vitamin D. Mutations in VDR gene FokI have been suggested in the development of various cancers. Whether the polymorphism of the VDR gene FokI confers risk to ovarian cancer still remains controversial across the published studies in different ethnicity. The aim of this meta-analysis was to determine the role of VDR gene FokI variant in the susceptibility to ovarian cancer. Six publications with 14 individual case-control studies involving a total of 10,964 subjects were finally included into our study after a comprehensive literature search of the PubMed, Embase, Web of Science, and Wanfang databases. The strength of the association between the VDR gene FokI polymorphism and ovarian cancer risk was estimated under the allelic (T vs. C), homozygous (TT vs. CC), additive (CT vs. CC), recessive (TT vs. CC + CT), and dominant (CT + TT vs. CC) gene models. The overall odds ratios (ORs) for the contrast models of T vs. C, TT vs. CC, CT vs. CC, and CT + TT vs. CC indicated that the VDR gene FokI variant was related to an increased risk of ovarian cancer (OR(T vs. C) = 1.09, 95 % confidence interval (CI) 1.03-1.15, P(OR) = 0.004; OR(TT vs. CC) = 1.17, 95 % CI 1.04-1.32, P(OR) = 0.011; OR(CT vs. CC) = 1.10, 95 % CI 1.01-1.20, P(OR) = 0.027; OR(CT + TT vs. CC) = 1.12, 95 % CI 1.03-1.21, P(OR) = 0.007). The stratified analysis among the Caucasians also identified a significant association between the VDR gene FokI polymorphism and the susceptibility to ovarian cancer. The present meta-analysis with large available published data has revealed that the VDR gene FokI polymorphism confers susceptibility to ovarian cancer, particularly among the Caucasian population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24078452     DOI: 10.1007/s13277-013-0826-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  48 in total

1.  Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.

Authors:  Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Michael E Carney; Rachel T Palmieri; Paul D P Pharoah; Honglin Song; Estrid Hogdall; Susanne Kruger Kjaer; Richard A DiCioccio; Valerie McGuire; Alice S Whittemore; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; Susan J Ramus; Marc T Goodman
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

Review 2.  Ovarian cancer.

Authors:  C Westhoff
Journal:  Annu Rev Public Health       Date:  1996       Impact factor: 21.981

Review 3.  The epidemiology of endometrial and ovarian cancer.

Authors:  Daniel W Cramer
Journal:  Hematol Oncol Clin North Am       Date:  2011-11-25       Impact factor: 3.722

4.  Promoter and 3'-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study.

Authors:  Yue Fang; Joyce B J van Meurs; Arnold d'Alesio; Mila Jhamai; Hongyan Zhao; Fernando Rivadeneira; Albert Hofman; Johannes P T van Leeuwen; Frédéric Jehan; Huibert A P Pols; André G Uitterlinden
Journal:  Am J Hum Genet       Date:  2005-09-26       Impact factor: 11.025

5.  Effects of vitamin D receptor gene polymorphisms on susceptibility to disease and bone mineral density in Turkish patients with type 1 diabetes mellitus.

Authors:  A Kocabaş; G Karagüzel; N Imir; U Yavuzer; S Akçurin
Journal:  J Pediatr Endocrinol Metab       Date:  2010-12       Impact factor: 1.634

Review 6.  Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.

Authors:  Donald L Trump; Kristin K Deeb; Candace S Johnson
Journal:  Cancer J       Date:  2010 Jan-Feb       Impact factor: 3.360

7.  Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line.

Authors:  M G Thomas; S Tebbutt; R C Williamson
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

Review 8.  Infertility as a cancer risk factor - a review.

Authors:  I Cetin; V Cozzi; P Antonazzo
Journal:  Placenta       Date:  2008-10       Impact factor: 3.481

9.  Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies.

Authors:  Shelley S Tworoger; Margaret A Gates; Margaret A Gate; I-Min Lee; Julie E Buring; Linda Titus-Ernstoff; Daniel Cramer; Susan E Hankinson
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

10.  Occupational exposures and the risk of ovarian cancer in Sweden.

Authors:  Tammy Shields; Gloria Gridley; Tahere Moradi; Johanna Adami; Nils Plato; Mustafa Dosemeci
Journal:  Am J Ind Med       Date:  2002-09       Impact factor: 2.214

View more
  3 in total

1.  Decreased expression of CYP27B1 correlates with the increased aggressiveness of ovarian carcinomas.

Authors:  Anna A Brożyna; Wojciech Jóźwicki; Cezary Jochymski; Andrzej T Slominski
Journal:  Oncol Rep       Date:  2014-12-11       Impact factor: 3.906

2.  Evidence of differential effects of vitamin d receptor variants on epithelial ovarian cancer risk by predicted vitamin d status.

Authors:  Jennifer Prescott; Kimberly A Bertrand; Brett M Reid; Jennifer Permuth-Wey; Immaculata De Vivo; Daniel W Cramer; Kathryn L Terry; Shelley S Tworoger
Journal:  Front Oncol       Date:  2014-10-20       Impact factor: 5.738

3.  Epidemiology of ovarian cancer: a review.

Authors:  Brett M Reid; Jennifer B Permuth; Thomas A Sellers
Journal:  Cancer Biol Med       Date:  2017-02       Impact factor: 4.248

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.